- Home
- SAVA vs PGRU Comparison
SAVA vs PGRU Comparison
Compare SAVA & PGRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- PGRU
- Stock Information
- Founded
- SAVA 1998
- PGRU 2006
- Country
- SAVA United States
- PGRU Singapore
- Employees
- SAVA N/A
- PGRU N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- PGRU EDP Services
- Sector
- SAVA Health Care
- PGRU Technology
- Exchange
- SAVA Nasdaq
- PGRU Nasdaq
- Market Cap
- SAVA 1.3B
- PGRU 1.1B
- IPO Year
- SAVA N/A
- PGRU N/A
- Fundamental
- Price
- SAVA $26.91
- PGRU $6.64
- Analyst Decision
- SAVA Strong Buy
- PGRU Buy
- Analyst Count
- SAVA 3
- PGRU 2
- Target Price
- SAVA $111.50
- PGRU $7.00
- AVG Volume (30 Days)
- SAVA 1.3M
- PGRU 111.9K
- Earning Date
- SAVA 11-07-2024
- PGRU 11-26-2024
- Dividend Yield
- SAVA N/A
- PGRU N/A
- EPS Growth
- SAVA N/A
- PGRU N/A
- EPS
- SAVA N/A
- PGRU N/A
- Revenue
- SAVA N/A
- PGRU $116,419,914.00
- Revenue This Year
- SAVA N/A
- PGRU $14.24
- Revenue Next Year
- SAVA N/A
- PGRU $18.14
- P/E Ratio
- SAVA N/A
- PGRU N/A
- Revenue Growth
- SAVA N/A
- PGRU 9.47
- 52 Week Low
- SAVA $8.79
- PGRU $3.15
- 52 Week High
- SAVA $42.20
- PGRU $6.65
- Technical
- Relative Strength Index (RSI)
- SAVA 51.05
- PGRU 59.61
- Support Level
- SAVA $25.00
- PGRU $6.61
- Resistance Level
- SAVA $28.18
- PGRU $6.65
- Average True Range (ATR)
- SAVA 1.81
- PGRU 0.02
- MACD
- SAVA 0.07
- PGRU -0.00
- Stochastic Oscillator
- SAVA 62.39
- PGRU 75.00
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About PGRU PropertyGuru Group Limited
PropertyGuru Group Ltd is a property technology company. The company provides digital property marketplaces to match buyers and tenants with sellers and landlords, digital marketing services for property agents and developers, SaaS-based sales process automation for property developers, a digital mortgage marketplace and brokerage, and property data consultancy services for banks, valuers and property developers. Their operating segments and reportable segments are each of its four marketplaces, Singapore, Vietnam, Malaysia and Other Asia, and Fintech and data services.